Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Respiratory tract delivery of levodopa and DOPA decarboxylase inhibitor for treatment of Parkinson's Disease

Respiratory tract delivery of levodopa and DOPA decarboxylase inhibitor for treatment of Parkinson's Disease

US Patent 11517548 · Granted Dec 6, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Nozzles for nasal drug delivery2024
Single-use nasal delivery device2024
Nasal drug delivery device with detachable nozzle2023
Intranasal delivery of olanzapine by precision olfactory device2023
Intranasal delivery of olanzapine by precision olfactory device2023
Intranasal delivery of olanzapine by precision olfactory device2023
Intranasal delivery of olanzapine by precision olfactory device2023
Nasal drug delivery device2023
Respiratory tract delivery of levodopa and DOPA decarboxylase inhibitor for trea2023
Respiratory tract delivery of levodopa and DOPA decarboxylase inhibitor for trea2023
Respiratory tract delivery of levodopa and DOPA decarboxylase inhibitor for trea2023
Respiratory tract delivery of levodopa and DOPA decarboxylase inhibitor for trea2023